Compare SLS & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLS | UMAC |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.7M | 770.8M |
| IPO Year | 2007 | 2023 |
| Metric | SLS | UMAC |
|---|---|---|
| Price | $4.92 | $13.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 4.0M | 3.5M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.00 | ★ 80.73 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,199,217.00 |
| Revenue This Year | N/A | $115.39 |
| Revenue Next Year | $110.98 | $101.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 101.23 |
| 52 Week Low | $1.39 | $4.67 |
| 52 Week High | $6.14 | $23.38 |
| Indicator | SLS | UMAC |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 44.91 |
| Support Level | $4.70 | $13.42 |
| Resistance Level | $5.28 | $17.03 |
| Average True Range (ATR) | 0.27 | 1.10 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 55.65 | 7.19 |
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Unusual Machines Inc is engaged in manufactures and sells drone components and drones across a diversified brand portfolio through business-to-business (B2B) sales and a curated retail channel.